Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study (Q113914197)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study |
scientific article published in 2022 |
Statements
1 reference
Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study (English)
1 reference
1 reference
Roberto Rodriguez‐Labrada
1 reference
Ricardo Ortega‐Sanchez
1 reference
Patricia Hernández Casaña
1 reference
Orestes Santos Morales
1 reference
Maria del Carmen Padrón‐Estupiñan
1 reference
Maricela Batista‐Nuñez
1 reference
Daise Jiménez Rodríguez
1 reference
Nalia Canales‐Ochoa
1 reference
Arnoy Peña Acosta
1 reference
Jacqueline Medrano Montero
1 reference
Pedro Enrique Labrada Aguilera
1 reference
Annelie Estupiñán Rodriguez
1 reference
Yaimee Vazquez‐Mojena
1 reference
Dennis Almaguer Gotay
1 reference
Judey Aymed‐García
1 reference
Idrian García‐García
1 reference
Reydenis Torres Vega
1 reference
Carmen Viada González
1 reference
Carmen M. Valenzuela Silva
1 reference
Yanelis Silva Ricardo
1 reference
Jorge Columbié Ximelis
1 reference
Kenia Tribin Rivero
1 reference
Roselin Valle Cabrera
1 reference
Julio Cesar García‐Rodriguez
1 reference
Tania Crombet Ramos
1 reference
Daniel Amaro‐González
1 reference
Teresita Rodriguez‐Obaya
1 reference
23 May 2022
1 reference
1 reference
37
1 reference
1516-1525
1 reference
7
1 reference
Identifiers
1 reference